What is happening, page-2590

Archer’s biochip gFET design for advanced sensing validated by commercial foundry partner Archer Materials Limited (ASX: AXE) has had its advanced graphene field effect transistor (“gFET”) chip design validated by a commercial foundry partner in the Netherlands with a whole four-inch wafer run. Highlights: Archer Materials’ commercial foundry partner in the Netherlands has validated its advanced biochip gFET design by manufacturing the chips using whole four-inch wafer semiconductor fabrication processes. The new gFET design for multiplexing was fabricated at a commercial scale foundry. The validation of the new advanced gFET device design and whole wafer run in a commercial foundry represents a critical milestone in the commercialisation pathway for Archer’s biochip. Archer now intends to integrate more functionality on the biochip, and optimise the device size and geometry to build advanced sensing regions. The biochip designs and devices form the basis of intellectual property that is 100% owned by Archer. Commenting on the validation of the advanced gFET design, Dr Mohammad Choucair, CEO of Archer said: "Archer’s biochip graphene sensor technology has essentially undergone translation from design to scalable semiconductor processing in a commercial foundry, which is both a key technology development and commercial milestone. "The whole wafer fabrication of the gFET device design is a significant step towards industrial production. Archer is continuing to strengthen its relationships with global foundry partners to deliver these chips using a streamlined ‘fabless’ commercialisation model."